Literature DB >> 14337993

MELANOMA OF THE EXTREMITIES; EXPERIENCES WITH CONVENTIONAL TREATMENT AND PERFUSION IN 339 CASES.

J S STEHLIN, R L CLARK.   

Abstract

Keywords:  AMPUTATION; EXTREMITIES; ISOLATION PERFUSION; LYMPH NODE EXCISION; MELANOMA; MORTALITY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM THERAPY; PROGNOSIS; SURGERY, OPERATIVE

Mesh：

Year:  1965        PMID： 14337993     DOI： 10.1016/0002-9610(65)90076-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  8 in total

1.  Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.

Authors:  C M McBride; E V Sugarbaker; R C Hickey
Journal:  Ann Surg       Date:  1975-09       Impact factor: 12.969

2.  The role of perfusion therapy in malignant melanoma.

Authors:  J A Key
Journal:  Can Med Assoc J       Date:  1968-07-06       Impact factor: 8.262

3.  Chemotherapy of malignant melanoma.

Authors:  G Westbury
Journal:  Proc R Soc Med       Date:  1970-01

4.  Isolated regional perfusion; anaesthetic technique, monitoring and blood replacement.

Authors:  M E Goldberg; H M Rosenblum; J L Seltzer; F E Rosato
Journal:  Can Anaesth Soc J       Date:  1984-09

5.  Isolated regional lymph node dissection: morbidity, mortality and economic considerations.

Authors:  K I Bland; T W Klamer; H C Polk; C O Knutson
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

6.  Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience.

Authors:  E T Krementz; R F Ryan
Journal:  Ann Surg       Date:  1972-06       Impact factor: 12.969

7.  Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines.

Authors:  T D Quinn; H C Polk; M J Edwards
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

8.  The extent of primary melanoma excision. A re-evaluation--how wide is wide?

Authors:  D R Aitken; K Clausen; J P Klein; A G James
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.